Coxiella burnetii (Q-Fever), Molecular Detection, PCR
Q fever is caused by a rickettsial organism known as Coxiella burnetii. It is a zoonotic disease, with transmission most likely through inhalation of aerosols from common reservoirs, sheep, and cattle. It can also be transmitted by tick bites (ixodid ticks), and by consuming raw or improperly pasteurized milk infected with bacterium. Clinical presentation is similar to that of severe influenza; however, usually no rash develops. Signs and symptoms include severe headache, high fever, a dry cough, and occasionally interstitial pneumonitis. There is a vaccine available to high-risk individuals and research workers. Usually treatment with tetracycline is very effective.
Of all bacteria this organism is among the most heat resistant, and pasteurization is needed for its elimination from milk. The bacterium exists in two antigenic phases in the blood called phase I and phase II. In acute cases anti-phase II antigen antibody is usually much higher than that of phase I antigen and is often detected by days 8 to 13 of illness. Phase I antibodies appear weeks to months later. Diagnosis of Q fever is usually confirmed by serologic findings of anti-phase II antigen IgM titers of 1:50 and IgG titers of 1:200. The finding of elevated levels of both IgM and IgA by ELISA has both high sensitivity and high specificity for acute Q fever.
In chronic Q fever, phase I antibodies, especially IgG and IgA, are predominant. Occasionally, titers do not rise for 4–6 weeks, especially if antimicrobial therapy has been given. Initial testing may not be helpful; treatment should be based on clinical and other laboratory assessment. As with any serologic procedure, demonstration of seroconversion or a fourfold increase in titer between acute and convalescent sera suggests current or recent infection. It is important to know that patients with Q fever have a high prevalence of antiphospholipid antibody. If chronic disease (which frequently includes endocarditis) is suspected, testing for phase I antibodies is indicated; if acute disease is suspected, testing for phase II antibodies is indicated. Recent studies have shown that greater accuracy in the diagnosis of Q fever can be achieved by looking at specific levels of classes of antibodies other than IgG, namely IgA and IgM. Combined detection of IgM and IgA in addition to IgG improves the specificity of the assays and provides better accuracy in diagnosis. IgM levels are helpful in the determination of a recent infection. In acute Q fever, patients will have IgG antibodies to phase II and IgM antibodies to phases I and II. Increased IgG and IgA antibodies to phase I are often indicative of Q fever endocarditis.
- Diagnosis of Q fever (acute or chronic Q fever)
- Differential diagnosis of Q fever in patient with similar symptom
- Evaluation of immune status to C. burnetii
Increased in:
- Acute or chronic Q fever
- Endocarditis of Q fever origin
- Vaccinated patients
Note: Specimens that are negative early in the course should be redrawn if clinical suspicious persists.
Negative (Non-reactive)
Formalin fixed paraffin embedded (FFPE) tissue samples.
Stability
Formalin fixed paraffin embedded (FFPE) tissue samples are stable at room temperature for longer.
- BMC Microbiol. 2006 Jan 19;6:2. [PMID: 16423303]
- J Clin Microbiol. 2006;44:2283. [PMID: 16757641]
- Eur Heart J. 1995 Apr;16 Suppl B:19-23. [PMID: 7671918]
- Murray PR et al (editors). Manual of Clinical Microbiology, 8th ed. ASM Press (2003)